Fintel reports that on July 15, 2024, JP Morgan upgraded their outlook for Solid Biosciences (NasdaqGS:SLDB) from Neutral to Overweight.
Analyst Price Forecast Suggests 96.96% Upside
As of July 4, 2024, the average one-year price target for Solid Biosciences is $16.83/share. The forecasts range from a low of $12.12 to a high of $21.00. The average price target represents an increase of 96.96% from its latest reported closing price of $8.54 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Solid Biosciences is 5MM, an increase of ∞%. The projected annual non-GAAP EPS is -2.23.
What is the Fund Sentiment?
There are 83 funds or institutions reporting positions in Solid Biosciences. This is an increase of 18 owner(s) or 27.69% in the last quarter. Average portfolio weight of all funds dedicated to SLDB is 0.24%, an increase of 138.77%. Total shares owned by institutions increased in the last three months by 109.75% to 35,073K shares. 
The put/call ratio of SLDB is 1.23, indicating a bearish outlook.
What are Other Shareholders Doing?
Perceptive Advisors holds 6,907K shares representing 18.00% ownership of the company. In its prior filing, the firm reported owning 3,496K shares , representing an increase of 49.38%. The firm increased its portfolio allocation in SLDB by 233.46% over the last quarter.
Ra Capital Management holds 4,330K shares representing 11.28% ownership of the company. In its prior filing, the firm reported owning 3,426K shares , representing an increase of 20.88%. The firm increased its portfolio allocation in SLDB by 125.10% over the last quarter.
Bain Capital Life Sciences Investors holds 4,035K shares representing 10.51% ownership of the company. In its prior filing, the firm reported owning 3,130K shares , representing an increase of 22.41%. The firm increased its portfolio allocation in SLDB by 134.42% over the last quarter.
Adage Capital Partners Gp, L.l.c. holds 2,539K shares representing 6.62% ownership of the company.
Artal Group holds 2,500K shares representing 6.51% ownership of the company. In its prior filing, the firm reported owning 909K shares , representing an increase of 63.63%. The firm increased its portfolio allocation in SLDB by 357.11% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
